BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9419977)

  • 1. Engineered mutants of pRB with improved growth suppression potential.
    Antelman D; Perry S; Hollingsworth R; Gregory RJ; Driscoll B; Fung YK; Bookstein R
    Oncogene; 1997 Dec; 15(23):2855-66. PubMed ID: 9419977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
    Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
    EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
    Chew YP; Ellis M; Wilkie S; Mittnacht S
    Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
    Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation.
    Hertel L; Rolle S; De Andrea M; Azzimonti B; Osello R; Gribaudo G; Gariglio M; Landolfo S
    Oncogene; 2000 Jul; 19(32):3598-608. PubMed ID: 10951565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
    Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
    Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
    Ahmad N; Gupta S; Mukhtar H
    Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma protein recruits histone deacetylase to repress transcription.
    Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
    Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
    Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
    Nath N; Wang S; Betts V; Knudsen E; Chellappan S
    Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of E2F activity by p21Waf1/Cip1.
    Delavaine L; La Thangue NB
    Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
    Alevizopoulos K; Sanchez B; Amati B
    Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cell cycle effects induced by E2F1 mutants.
    Qin XQ; Barsoum J
    Oncogene; 1997 Jan; 14(1):53-62. PubMed ID: 9010232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.